Search research articles
Contact Us
Filters
Showing results (241-250 of 365) with videos related to
Page
of 37
Sort By:
Plos One
|
April 1, 2015
Prediction of week 4 virological response in hepatitis C for making decision on triple therapy: the Optim study
Manuel Romero-Gómez, Juan Turnes, Javier Ampuero, et al.
Journal of Clinical Medicine
|
September 9, 2023
Risk of Recurrence of Hepatocarcinoma after Liver Transplantation: Performance of Recurrence Predictive Models in a Cohort of Transplant Patients
Antonio Cuadrado, José Ignacio Fortea, Carlos Rodríguez-Lope, et al.
Journal of Hepatology
|
December 19, 2024
Carvedilol vs. propranolol for the prevention of decompensation and mortality in patients with compensated and decompensated cirrhosis
Jose Ignacio Fortea, Edilmar Alvarado-Tapias, Benedikt Simbrunner, et al.
Medicina Clinica
|
November 9, 2007
[Adefovir dipivoxil compassionate use program in Spain: efficacy and resistance analysis]
María Buti, Francisco Rodríguez Frías, José Luis Calleja, et al.
Gastroenterologia Y Hepatologia
|
January 22, 2026
Multidisciplinary clinical practice guideline on the management of metabolic hepatic steatosis
Manuel Romero-Gómez, Javier Escalada, Mar Noguerol, et al.
United European Gastroenterology Journal
|
July 19, 2019
Liver injury after methylprednisolone pulses: A disputable cause of hepatotoxicity. A case series and literature review
Miguel Eugenio Zoubek, José Pinazo-Bandera, Aida Ortega-Alonso, et al.
Journal of Hepatology
|
September 6, 2025
Erratum to 'Carvedilol vs. propranolol for the prevention of decompensation and mortality in patients with compensated and decompensated cirrhosis' [J Hepatol 83 (2025) 70-80]
Jose Ignacio Fortea, Edilmar Alvarado-Tapias, Benedikt Simbrunner, et al.
Annals of Hepatology
|
January 8, 2013
Safety and efficacy of treatment with pegylated interferon alpha-2a with ribavirin in chronic hepatitis C genotype 4
Juan José Urquijo, Moisés Diago, Jaume Boadas, et al.
Journal of Clinical Medicine
|
September 4, 2020
Portal Thrombosis in Cirrhosis: Role of Thrombophilic Disorders
José Ignacio Fortea, Inés García Carrera, Ángela Puente, et al.
Transplantation
|
March 24, 2022
Immune Response After a Third Dose of the mRNA-1273 SARS-CoV-2 Vaccine in Liver Transplant Recipients
Aitor Odriozola, Patricia Lamadrid-Perojo, Antonio Cuadrado, et al.
Page
of 37
Search research articles
Search
Showing results (241-250 of 365) with videos related to
Sort By:
Page
of 37
Plos One
|
April 1, 2015
Prediction of week 4 virological response in hepatitis C for making decision on triple therapy: the Optim study
Manuel Romero-Gómez, Juan Turnes, Javier Ampuero, et al.
Journal of Clinical Medicine
|
September 9, 2023
Risk of Recurrence of Hepatocarcinoma after Liver Transplantation: Performance of Recurrence Predictive Models in a Cohort of Transplant Patients
Antonio Cuadrado, José Ignacio Fortea, Carlos Rodríguez-Lope, et al.
Journal of Hepatology
|
December 19, 2024
Carvedilol vs. propranolol for the prevention of decompensation and mortality in patients with compensated and decompensated cirrhosis
Jose Ignacio Fortea, Edilmar Alvarado-Tapias, Benedikt Simbrunner, et al.
Medicina Clinica
|
November 9, 2007
[Adefovir dipivoxil compassionate use program in Spain: efficacy and resistance analysis]
María Buti, Francisco Rodríguez Frías, José Luis Calleja, et al.
Gastroenterologia Y Hepatologia
|
January 22, 2026
Multidisciplinary clinical practice guideline on the management of metabolic hepatic steatosis
Manuel Romero-Gómez, Javier Escalada, Mar Noguerol, et al.
United European Gastroenterology Journal
|
July 19, 2019
Liver injury after methylprednisolone pulses: A disputable cause of hepatotoxicity. A case series and literature review
Miguel Eugenio Zoubek, José Pinazo-Bandera, Aida Ortega-Alonso, et al.
Journal of Hepatology
|
September 6, 2025
Erratum to 'Carvedilol vs. propranolol for the prevention of decompensation and mortality in patients with compensated and decompensated cirrhosis' [J Hepatol 83 (2025) 70-80]
Jose Ignacio Fortea, Edilmar Alvarado-Tapias, Benedikt Simbrunner, et al.
Annals of Hepatology
|
January 8, 2013
Safety and efficacy of treatment with pegylated interferon alpha-2a with ribavirin in chronic hepatitis C genotype 4
Juan José Urquijo, Moisés Diago, Jaume Boadas, et al.
Journal of Clinical Medicine
|
September 4, 2020
Portal Thrombosis in Cirrhosis: Role of Thrombophilic Disorders
José Ignacio Fortea, Inés García Carrera, Ángela Puente, et al.
Transplantation
|
March 24, 2022
Immune Response After a Third Dose of the mRNA-1273 SARS-CoV-2 Vaccine in Liver Transplant Recipients
Aitor Odriozola, Patricia Lamadrid-Perojo, Antonio Cuadrado, et al.
Page
of 37